AllianceBernstein provides investment management services to institutional (42% of assets under management), retail (39%), and private (19%) clients through products that include mutual funds, hedge funds, and separately managed accounts... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TXNU | 48.96 | 4.34 | +9.73% |
| Direxion Daily TXN Bull 2X ETF (TXNU) | |||
| USVM | 105.38 | 0.61 | +0.58% |
| VictoryShares US Small Mid Cap Value Momentum ETF (USVM) | |||
| HTEC | 44.53 | 0.11 | +0.25% |
| ROBO Global Healthcare Technology and Innovation ETF (HTEC) | |||
| PATN | 36.12 | N/A | N/A |
| PACER FDS TR | |||
| WBIG | 26.96 | -0.01 | -0.05% |
| WBI BullBear Yield 3000 ETF (WBIG) | |||
A.I.dvisor indicates that over the last year, AB has been loosely correlated with NEWT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if AB jumps, then NEWT could also see price increases.
a provider of diversified, global investment management to institutional, high net-worth and retail clients
Industry InvestmentManagers
The RSI Indicator for AB moved out of oversold territory on October 14, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In 23 of the 26 cases the stock moved higher. This puts the odds of a move higher at 88%.
The Momentum Indicator moved above the 0 level on October 23, 2026. You may want to consider a long position or call options on AB as a result. In 51 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 59%.
The Moving Average Convergence Divergence (MACD) for AB just turned positive on October 20, 2026. Looking at past instances where AB's MACD turned positive, the stock continued to rise in 30 of 51 cases over the following month. The odds of a continued upward trend are 59%.
Following a +1.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where AB advanced for three days, in 154 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 52%.
AB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
The Aroon Indicator for AB entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 55 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 69 (best 1 - 100 worst), indicating slightly worse than average price growth. AB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 89 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.637) is normal, around the industry mean (2.383). P/E Ratio (10.531) is within average values for comparable stocks, (-2.559). Projected Growth (PEG Ratio) (0.714) is also within normal values, averaging (1.319). Dividend Yield (0.093) settles around the average of (0.272) among similar stocks. P/S Ratio (9.625) is also within normal values, averaging (15.798).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.